Maher Hanoun Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

4/2024	Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
3/2024	Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence.
7/2023	Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
1/2023	Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
1/2023	Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
1/2022	Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
10/2021	Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
1/2020	Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia.
1/2019	FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maher Hanoun Research Topics

Disease

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2019
4	Leukemia 04/2024 - 01/2019
3	Neoplasms (Cancer) 01/2023 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 01/2019
2	Neutropenia 10/2023 - 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Philadelphia Chromosome 10/2023
1	Anemia 10/2023
1	Leukopenia 10/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2023
1	Trisomy (Trisomies) 01/2023
1	Disease Progression 06/2021
1	Hemorrhage 06/2021
1	Hypersensitivity (Allergy) 06/2021
1	Infections 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Lymphoma (Lymphomas) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2012

Drug/Important Bio-Agent (IBA)

1	venetoclaxIBA 04/2024
1	Cetrimonium (CTAB)IBA 03/2024
1	Inotuzumab OzogamicinIBA 10/2023
1	EnzymesIBA 10/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2023
1	CohesinsIBA 01/2023
1	ChromatinIBA 01/2023
1	CPX-351IBA 10/2021
1	Phenprocoumon (Liquamar)FDA Link 06/2021
1	Vitamin K FDA Link 06/2021
1	AnticoagulantsIBA 06/2021
1	factor IX CambridgeIBA 06/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 06/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2021
1	Dipyrone (Metamizole)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	CytokinesIBA 01/2020
1	Janus KinasesIBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2019
1	CryptochromesIBA 01/2012

Therapy/Procedure

6	Therapeutics 04/2024 - 01/2020
3	Cell Transplantation 01/2023 - 01/2019
2	Salvage Therapy 01/2020 - 01/2019
1	Stem Cell Transplantation 07/2023
1	Drug Therapy (Chemotherapy) 07/2023
1	Transplantation 01/2019